Dr Christopher Wenzinger, MD | |
70 Medical Center Cir Ste 309, Fisherville, VA 22939-2273 | |
(540) 332-5885 | |
(540) 332-5888 |
Full Name | Dr Christopher Wenzinger |
---|---|
Gender | Male |
Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
Location | 70 Medical Center Cir Ste 309, Fisherville, Virginia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1356789101 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | LL35849 (South Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Christopher Wenzinger, MD 70 Medical Center Cir Ste 309, Fisherville, VA 22939-2273 Ph: (540) 332-5885 | Dr Christopher Wenzinger, MD 70 Medical Center Cir Ste 309, Fisherville, VA 22939-2273 Ph: (540) 332-5885 |
News Archive
CardioMEMS, Inc., a medical technology company that has developed and is commercializing proprietary wireless sensing and communication technology for the human body, today announced the completion of a $22.1M financing. The financing provides the company with additional capital to fund the company's CHAMPION clinical trial.
With anxiety and depression on the rise amid the challenges of the COVID-19 pandemic, a West Virginia University-led study seeks to identify mental health issues and test online treatments among West Virginians at home - particularly those in rural areas, where access to clinical services is limited.
Minnesota is one of only six states that covers all recommended tobacco cessation medications and counseling for its citizens coved by Medicare, according to an annual "report card" issued today by the American Lung Association. Indiana, Massachusetts, Nevada, Oregon and Pennsylvania are the other states honored with a 'thumbs up,' although no state earned an "A" grade for cessation coverage this year.
This is a follow up study to one released last Thursday in the New England Journal of Medicine on the effects of antidepressants in the treatment of bipolar disorder. Both studies, called STEP-BD, were funded by the National Institute of Mental Health.
Critics are worried that the concept of accountable care organizations could backfire, HealthyCal reports.
› Verified 8 days ago